News
- Author:
- Caleb Rans
Publish date: July 5, 2019
The tyrosine kinase inhibitor dasatinib was found to transiently inhibit CAR T-cell function in a preclinical study, suggesting applicability as an...
News
- Author:
- Caleb Rans
Publish date: July 5, 2019
At final follow-up, in a case series of 12 patients with relapsed/refractory DLBCL, the best objective response rate was 81.8%, with complete respo...
News
- Author:
- Caleb Rans
Publish date: July 5, 2019
Polatuzumab vedotin plus rituximab or obinutuzumab, in addition to cyclophosphamide, doxorubicin, and prednisone, showed manageable safety and posi...
News
- Author:
- Caleb Rans
Publish date: July 5, 2019
Routine outpatient vaccination screening and strategies for sharing and linking patient vaccination status could improve vaccination documentation....
News
- Author:
- Caleb Rans
Publish date: July 2, 2019
In a pharmacokinetic crossover study of 18 patients with severe hemophilia A, the median time to achieve factor VIII threshold levels (1 IU/dL) was...
News
- Author:
- Caleb Rans
Publish date: June 25, 2019
For previously untreated patients with severe hemophilia A, the risk for developing factor VIII inhibitors is near zero after 75 exposure days.
News
- Author:
- Caleb Rans
Publish date: June 24, 2019
“Associations were stronger in [dementia] cases diagnosed before the age of 80 years,” the researchers noted.
News
- Author:
- Caleb Rans
Publish date: June 21, 2019
A postmarketing study in Japan shows high rates of effectiveness for both routine prophylaxis and on-demand treatment with the recombinant factor I...
News
- Author:
- Caleb Rans
Publish date: June 19, 2019
These chip systems could potentially reduce the use of animals and increase the efficiency of drug evaluations in preclinical studies.
News
- Author:
- Caleb Rans
Publish date: June 19, 2019
In a phase 3 trial of patients with stage III or IVA endometrial cancer, the proportion of patients alive and relapse free at 60 months was 59% an...
News
- Author:
- Caleb Rans
Publish date: June 17, 2019
Long-term low levels of LDL cholesterol by means of PCSK9 gene variation correspond with reduced risk of cardiovascular death.
News
- Author:
- Caleb Rans
Publish date: June 13, 2019
The need for treatment with VWF concentrate appeared low in the study cohort, with the exception of patients with severe disease.
News
- Author:
- Caleb Rans
Publish date: June 13, 2019
A small study shows that hepatectomy appears safe for the treatment of hepatocellular carcinoma in patents with hemophilia and von Willebrand disea...
News
- Author:
- Caleb Rans
Publish date: June 12, 2019
The sonographic HEAD-US scoring system had a strong correlation with the assessed joint bleeding rate for 3 years for ankles and knees, but not elb...
News
- Author:
- Caleb Rans
Publish date: June 12, 2019
Combining aerobic and resistance training appears to be the best approach for reducing proinflammatory markers in this population of patients.
